SPTLC1 and Alzheimer disease: The authors showed positive correlation between SPTLC1 and Aβ expression in AD brain, and suggested that the downregulation of miR-181c can increase the abundance of pathogenic Aβ by dysregulating the expression of SPTLC1 and increasing the levels of ceramide [153].